San Jose, CA, United States of America

Abigail Yu

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.7

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Abigail Yu in Antibody Conjugates

Introduction

Abigail Yu is a prominent inventor based in San Jose, CA, known for her significant contributions to the field of biotechnology. She has been instrumental in developing innovative antibody conjugates that target specific receptors, showcasing her expertise in therapeutic applications.

Latest Patents

Abigail Yu holds 3 patents related to her groundbreaking work. Her latest patents include "Anti-ROR1 antibody conjugates," "Compositions comprising anti-ROR1 antibody conjugates," and "Methods of making and using anti-ROR1 antibody conjugates." These patents focus on antibodies and antibody conjugates that specifically bind to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. The disclosures also cover methods for producing these antibodies and their applications in therapeutic and diagnostic methods.

Career Highlights

Abigail Yu is currently associated with Sutro Biopharma, Inc., where she continues to advance her research in antibody drug conjugates. Her work has the potential to significantly impact the treatment of various diseases by providing targeted therapeutic options.

Collaborations

Abigail collaborates with talented professionals in her field, including Ryan Stafford and Alice Yam. These collaborations enhance her research and contribute to the development of innovative solutions in biotechnology.

Conclusion

Abigail Yu's contributions to the field of antibody conjugates exemplify her dedication to innovation and research. Her patents and ongoing work at Sutro Biopharma, Inc. highlight her role as a leading inventor in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…